Malignant Pleural Effusion: Diagnosis and Management
Symptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic ple...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2020/2950751 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832566173794828288 |
---|---|
author | Lucía Ferreiro Juan Suárez-Antelo José Manuel Álvarez-Dobaño María E. Toubes Vanessa Riveiro Luis Valdés |
author_facet | Lucía Ferreiro Juan Suárez-Antelo José Manuel Álvarez-Dobaño María E. Toubes Vanessa Riveiro Luis Valdés |
author_sort | Lucía Ferreiro |
collection | DOAJ |
description | Symptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic pleurodesis or thoracic drainage, indwelling pleural catheter, surgery, or a combination of these therapies). Despite the availability of therapies, the management of malignant pleural effusion is challenging and is mainly focused on the relief of symptoms. The therapy to be administered needs to be designed on a case-by-case basis considering patient’s preferences, life expectancy, tumour type, presence of a trapped lung, resources available, and experience of the treating team. At present, the management of malignant pleural effusion has evolved towards less invasive approaches based on ambulatory care. This approach spares the patient the discomfort caused by more invasive interventions and reduces the economic burden of the disease. A review was performed of the diagnosis and the different approaches to the management of malignant pleural effusion, with special emphasis on their indications, usefulness, cost-effectiveness, and complications. Further research is needed to shed light on the current matters of controversy and help establish a standardized, more effective management of this clinical problem. |
format | Article |
id | doaj-art-faf685b0b96047c0b0d6952ec4fdab56 |
institution | Kabale University |
issn | 1198-2241 1916-7245 |
language | English |
publishDate | 2020-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Respiratory Journal |
spelling | doaj-art-faf685b0b96047c0b0d6952ec4fdab562025-02-03T01:04:59ZengWileyCanadian Respiratory Journal1198-22411916-72452020-01-01202010.1155/2020/29507512950751Malignant Pleural Effusion: Diagnosis and ManagementLucía Ferreiro0Juan Suárez-Antelo1José Manuel Álvarez-Dobaño2María E. Toubes3Vanessa Riveiro4Luis Valdés5Pulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainPulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, SpainSymptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic pleurodesis or thoracic drainage, indwelling pleural catheter, surgery, or a combination of these therapies). Despite the availability of therapies, the management of malignant pleural effusion is challenging and is mainly focused on the relief of symptoms. The therapy to be administered needs to be designed on a case-by-case basis considering patient’s preferences, life expectancy, tumour type, presence of a trapped lung, resources available, and experience of the treating team. At present, the management of malignant pleural effusion has evolved towards less invasive approaches based on ambulatory care. This approach spares the patient the discomfort caused by more invasive interventions and reduces the economic burden of the disease. A review was performed of the diagnosis and the different approaches to the management of malignant pleural effusion, with special emphasis on their indications, usefulness, cost-effectiveness, and complications. Further research is needed to shed light on the current matters of controversy and help establish a standardized, more effective management of this clinical problem.http://dx.doi.org/10.1155/2020/2950751 |
spellingShingle | Lucía Ferreiro Juan Suárez-Antelo José Manuel Álvarez-Dobaño María E. Toubes Vanessa Riveiro Luis Valdés Malignant Pleural Effusion: Diagnosis and Management Canadian Respiratory Journal |
title | Malignant Pleural Effusion: Diagnosis and Management |
title_full | Malignant Pleural Effusion: Diagnosis and Management |
title_fullStr | Malignant Pleural Effusion: Diagnosis and Management |
title_full_unstemmed | Malignant Pleural Effusion: Diagnosis and Management |
title_short | Malignant Pleural Effusion: Diagnosis and Management |
title_sort | malignant pleural effusion diagnosis and management |
url | http://dx.doi.org/10.1155/2020/2950751 |
work_keys_str_mv | AT luciaferreiro malignantpleuraleffusiondiagnosisandmanagement AT juansuarezantelo malignantpleuraleffusiondiagnosisandmanagement AT josemanuelalvarezdobano malignantpleuraleffusiondiagnosisandmanagement AT mariaetoubes malignantpleuraleffusiondiagnosisandmanagement AT vanessariveiro malignantpleuraleffusiondiagnosisandmanagement AT luisvaldes malignantpleuraleffusiondiagnosisandmanagement |